The emergence of multidrug-resistant strains of the enteric pathogen is challenging clinicians and public health officials.
Join CIDRAP-ASP and the AMR Narrative on Rare Disease Day (Feb 28) at 4pm GMT for a 60-minute Twitter Chat about the impact of antimicrobial resistance on patients with rare diseases. It's the first in a series of collaborative events to encourage meaningful conversation around AMR among healthcare professionals, patients, and the public.
A CIDRAP-ASP report on the global burden of typhoid, the emergence of drug-resistant strains, and the role that typhoid conjugate vaccine campaigns could play in typhoid prevention and control.
True stories from scientists and pateients.
You can find all of CIDRAP-ASP's previous webinars on our YouTube channel.
Take the latest edition of our monthly quiz.
Help support our work on antimicrobial stewardship.
Be in the know about antimicrobial stewardship.
Our antimicrobial resistance factsheet
Antimicrobial resistance occurs when microbes, such as bacteria, evolve the ability to survive exposure to medicines previously used to treat them. Visit the antimicrobial resistance factsheet to learn more.
The Antimicrobial Resistance Toolkit
We developed a toolkit aimed at community practitioners and patients to provide basic information on antimicrobial resistance and responsible use of antibiotics. You can view and download the Toolkit here.
One Health Antimicrobial Stewardship
We are currently developing educational modules to raise awareness and increase the knowledge base about practical antibiotic stewardship implementation among veterinarians.
This study evaluated the cost-effectiveness and budget impact of treating invasive candidiasis (IC) with anidulafungin compared with amphotericin B deoxycholate or amphotericin B lipid complex, finding that incorporation of anidulafungin as a first-line therapy for IC could save the Brazilian health system up to R$150 million reais (about $29.2 million USD) over 5 years.
In this summary of the Histoplasmosis Porto Alegre Manifesto, following the May 2022 Brazilian Histoplasmosis Meeting, the authors call for urgent improvements to the availability of Histoplasma antigen testing and liposomal amphotericin B antifungal treatment.
Increasing numbers of infections in animals associated with resistant bacteria pose a challenge for veterinarians in the United States (US) and around the world. This review article presents existing efforts in the US, as well as challenges and opportunities, related to surveillance of AMR in veterinary medicine.